Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

Acute Coronary Syndrome V: Nursing Management

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...

Inhalational Anesthetics: Overview

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...

Increased Intracranial Pressure l: Introduction

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diving exposure and pulmonary stress.

The Journal of physiology·2026

Same author

Gas Embolism: Fundamentals, Diagnosis, and Treatment.

IEEE reviews in biomedical engineering·2026

Same author

Gas exchange and pulmonary stress variations during SCUBA and breath-hold diving in open seawater.

The Journal of physiology·2026

Same author

Advances in breath-hold diving research: a state-of-the-art review.

European journal of applied physiology·2025

Same author

Letter to the Editor Regarding Hyperbaric Oxygen Therapy (HBOT) for Management of Complex Regional Pain Syndrome.

The Clinical journal of pain·2025

Same author

Ultrasound detection of lymphatic bubbles in a porcine dive model.

Journal of applied physiology (Bethesda, Md. : 1985)·2025

Search research articles

Related Experiment Video

Updated: May 20, 2026

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Published on: February 24, 2023

Adjunctive therapy for decompression illness: a review and update.

Richard E Moon¹

¹Duke University Medical Center, Durham, NC, USA. moon0002@mc.duke.edu

Diving and Hyperbaric Medicine

|July 4, 2012

Summary

This study reviews therapeutic interventions for decompression sickness, including oxygen therapy, fluid resuscitation, and anti-inflammatory drugs. Lignocaine is noted for cerebral arterial gas embolism (CAGE), while heparin aids in paralysis cases.

More Related Videos

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

Published on: January 26, 2024

Minimally Invasive Surgical Decompression of Occipital Nerves

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Related Experiment Videos

Last Updated: May 20, 2026

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis

Published on: February 24, 2023

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

A Suture Technique for Ruptured Annulus Fibrosus Following Decompression Under Percutaneous Transforaminal Endoscopic Discectomy

Published on: January 26, 2024

Minimally Invasive Surgical Decompression of Occipital Nerves

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Area of Science:

Emergency Medicine
Diving Medicine
Pharmacology

Background:

Decompression sickness (DCS) requires prompt management to improve patient outcomes.
Therapeutic interventions can stabilize patients before recompression therapy.
Cerebral arterial gas embolism (CAGE) is a severe complication requiring specific treatments.

Purpose of the Study:

To outline effective therapeutic interventions for DCS and CAGE.
To review evidence supporting various treatments, including pharmacological and supportive measures.
To provide guidance on managing specific complications like paralysis and CAGE.

Main Methods:

Literature review of therapeutic strategies for DCS and CAGE.
Analysis of evidence for treatments such as oxygen therapy, NSAIDs, lignocaine, and heparin.
Evaluation of animal study findings on hyperventilation and perfluorocarbon efficacy.

Main Results:

Surface oxygen therapy, fluid resuscitation, NSAIDs, and fever avoidance are effective.
Lignocaine shows efficacy for CAGE.
Intravenous perfluorocarbon has strong experimental support in animals.
Low molecular weight heparin is recommended for paralysis to prevent venous thromboembolism.

Conclusions:

A combination of supportive care and targeted pharmacological interventions can significantly improve DCS and CAGE outcomes.
Specific treatments like lignocaine for CAGE and heparin for paralysis are crucial.
Further research into agents like perfluorocarbons may offer future therapeutic advancements.